Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
NGM Biopharmaceuticals
3200
NGM Biopharmaceuticals
Health Care
Medical
Technology
Biotechnology
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
Suggest edits
Founded
2007
Raised
$295.4M
Follow us
Also headquartered in South San Francisco
Genentech
insitro
MyoKardia
Sutro Biopharma
Freenome
SuccessFactors
Plenty
Theravance
Cytokinetics, Inc.
Dispatch
Companies in the same industry
Ceres Nanosciences
Prexton Therapeutics SA
Bioverativ
Hangzhou Just Biotherapeutics (Just China)
Auspherix
OxSyBio
Olema Pharmaceuticals
Gelesis
Amadix
Mycodev Group
Alexa global traffic share
Overview
Funding
5
Add info
Add round
26 Mar
2015
$57,500,000
Venture capital (Series D)
25 Mar
2015
$105,999,996
Venture capital (Series E)
18 Jul
2013
$50,000,000
Venture capital (Series C)
Rho Ventures
,
Topspin Partners
,
Prospect Venture Partners
,
+2
07 Nov
2011
$55,389,000
Venture capital (Series B)
Rho Capital Partners
,
Prospect Venture Partners
,
Tichenor Ventures
22 Dec
2009
$26,550,000
Venture capital (Series A)
Rho Capital Partners
,
Prospect Venture Partners
,
The Column Group
